Ancillary to ABC PICU to study MOD in critically ill children
辅助 ABC PICU 研究危重儿童的 MOD
基本信息
- 批准号:9534163
- 负责人:
- 金额:$ 39.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAdult Respiratory Distress SyndromeAngiopoietin-2BioinformaticsBiologicalBiological AssayBiological MarkersBiologyBloodBlood donorChildClinicalClinical ResearchClinical TrialsCoagulation ProcessCritical IllnessCritically ill childrenDataDevelopmentEnrollmentEnvironmentExpression ProfilingFunctional disorderFutureGenomicsGenotypeHemeIL8 geneIncidenceInflammationInflammatoryInjuryInterleukin-6IronKnowledgeLeadLinkMeasuresModelingMulti-Institutional Clinical TrialMultiple Organ FailureOrganOrgan failureOutcomePathologicPathway interactionsPatientsPatternPediatric Intensive Care UnitsPlasmaPlasminogen Activator Inhibitor 1PlayProcessProductionPrognostic MarkerPublishingReportingResearch InfrastructureRespiratory SystemRespiratory Tract InfectionsRiskRoleSamplingSepsisSeverity of illnessSuggestionSyndromeTestingThrombomodulinThrombosisTransfusionage effectbasebiomarker developmentcirculating biomarkersextracellulargenetic variantgut microbiomehigh riskimprovedinflammatory markerinsightmicrobialmicrobiomemicrobiome alterationmolecular markermolecular phenotypemortalityneutrophilnew therapeutic targetnext generation sequencingnovelprecision medicinepredictive markertargeted treatment
项目摘要
PROJECT SUMMARY/ABSTRACT
Multiple Organ Dysfunction Syndrome (MODS) occurs frequently in the setting of critical illnesses and is
associated with a nearly 10-fold higher mortality risk. It is a “syndrome” rather than a specific pathological entity
that is characterized by a severe, systemic, and uncontrolled inflammatory process. Several clinical studies
have reported that alterations in inflammation and coagulation are common in critically ill patients and may be
worsened by transfusion of RBCs. Our published and yet to be published data suggest that higher plasma
levels of IL-6, IL-8, PAI-1, Thrombomodulin (TM), and Angiopoietin -2 (Ang-2), and genetic variants in PAI-1
and TM are associated with increased organ dysfunction and mortality in critically ill children and adults.
Neutrophil Extracellular Traps (NETs), produced by activated neutrophils, have been reported to play a role in
organ injury, and extracellular heme released from transfused RBCs is known to trigger the production of
NETs. Our preliminary studies suggest that NETs tend to be increased in non-survivor children with MODS.
Finally, blood from healthy subjects contains a host of bacterial genomic material (microbiome) and this
circulating microbiome has the potential to lead to non-infectious inflammation, thereby contributing to MODS.
However, markers of altered inflammation and thrombosis, and the role of NETs and circulating microbiome
have not yet been studied rigorously in a sufficient number of critically ill children with MODS. We propose to
leverage the infrastructure of the ABC PICU study, an ongoing multi-center clinical trial to enroll critically ill
children undergoing RBC transfusions and collect biological samples pre- and post-transfusion (day 1, 3 and 5)
to characterize inflammation and coagulation related biomarkers and examine their relationship to the
development of NPMODS and mortality. In Aim1, we will assay plasma levels and expression profile of
selected markers (IL-6, IL-8, PAI-1,TM and Ang-2) and association of post-transfusion slope of change in the
measured biomarkers with NPMODS and mortality will be tested using mixed effect models. In Aim 2. we will
genotype tag SNPs and sequence target regions to detect genetic variants and assess their effect on
biomarker trajectories and development of NPMODS and mortality. In Aim 3, unbiased next generation
sequencing followed by alignment of non-human sequences will be used to identify and characterize the
circulating microbiome and we will test for association of microbial diversity and burden with circulating
biomarkers and NPMODS. This study will characterize prognostic and predictive biomarkers and provide
mechanistic insights that establish a link between these markers and the development of NPMODS. The
knowledge acquired and molecular phenotypes thus defined may identify novel therapeutic targets, and will
inform future clinical trials and lead to development of precision medicine strategies targeting therapeutic
agents to patients with specific molecular phenotypes or biomarker patterns.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANIL SAPRU其他文献
ANIL SAPRU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANIL SAPRU', 18)}}的其他基金
Ancillary to ABC PICU to study MOD in critically ill children
辅助 ABC PICU 研究危重儿童的 MOD
- 批准号:
9905545 - 财政年份:2017
- 资助金额:
$ 39.38万 - 项目类别:
Ancillary to ABC PICU to study MOD in critically ill children
辅助 ABC PICU 研究危重儿童的 MOD
- 批准号:
9368869 - 财政年份:2017
- 资助金额:
$ 39.38万 - 项目类别:
Collaborative Research to Validate Biomarkers of Pediatric ARDS
验证儿科 ARDS 生物标志物的合作研究
- 批准号:
8857732 - 财政年份:2014
- 资助金额:
$ 39.38万 - 项目类别:
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial
儿科胰岛素滴定试验中的凝血和纤溶
- 批准号:
8690137 - 财政年份:2012
- 资助金额:
$ 39.38万 - 项目类别:
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial
儿科胰岛素滴定试验中的凝血和纤溶
- 批准号:
8517183 - 财政年份:2012
- 资助金额:
$ 39.38万 - 项目类别:
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial
儿科胰岛素滴定试验中的凝血和纤溶
- 批准号:
8415716 - 财政年份:2012
- 资助金额:
$ 39.38万 - 项目类别:
Targeted Genomic Analysis of Coagulation Pathways in Acute Lung Injury
急性肺损伤凝血途径的靶向基因组分析
- 批准号:
7904846 - 财政年份:2007
- 资助金额:
$ 39.38万 - 项目类别:
Targeted Genomic Analysis of Coagulation Pathways in Acute Lung Injury
急性肺损伤凝血途径的靶向基因组分析
- 批准号:
7318993 - 财政年份:2007
- 资助金额:
$ 39.38万 - 项目类别:
Targeted Genomic Analysis of Coagulation Pathways in Acute Lung Injury
急性肺损伤凝血途径的靶向基因组分析
- 批准号:
7478459 - 财政年份:2007
- 资助金额:
$ 39.38万 - 项目类别:
Targeted Genomic Analysis of Coagulation Pathways in Acute Lung Injury
急性肺损伤凝血途径的靶向基因组分析
- 批准号:
8115795 - 财政年份:2007
- 资助金额:
$ 39.38万 - 项目类别:
相似海外基金
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6564818 - 财政年份:2001
- 资助金额:
$ 39.38万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6410976 - 财政年份:2000
- 资助金额:
$ 39.38万 - 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
- 批准号:
6370267 - 财政年份:2000
- 资助金额:
$ 39.38万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6418789 - 财政年份:2000
- 资助金额:
$ 39.38万 - 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
- 批准号:
6370266 - 财政年份:2000
- 资助金额:
$ 39.38万 - 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
- 批准号:
6370265 - 财政年份:2000
- 资助金额:
$ 39.38万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6302122 - 财政年份:1999
- 资助金额:
$ 39.38万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6309780 - 财政年份:1999
- 资助金额:
$ 39.38万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6109540 - 财政年份:1998
- 资助金额:
$ 39.38万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6265845 - 财政年份:1998
- 资助金额:
$ 39.38万 - 项目类别: